GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of endpoint — my 2-week log, condensed into one table — 67 comments in the full submission. View in context.
2.1k
c/trialwatch·submitted 3 months ago by u/yara_mensah

endpoint — my 2-week log, condensed into one table

Discussionbranch of 10 comments

Genuinely asking, not being difficult. Everyone in c/bloodwork repeats that SELECT is important. I believe it, but I have never seen anyone show why, and when I search I get 18 threads of people agreeing with each other. Is there a paper? Is there a measurement? Or is this one of those things that is true because it…

Read the full submission and all 67 comments →

This branch

10 comments, started 3 months ago
u/forest_plot_fionastats114 points·3 months ago

Is that absolute or relative risk reduction?

replysharereportpermalink
u/careful_gradient_again88 points·3 months ago

press release hazard ratio posts must be flaired until a publication exists

replysharereportpermalink
[deleted]35 points·3 months ago

[deleted]

replysharereportpermalink
u/sten_palacios21 points·3 months ago·edited

press release TRIUMPH posts must be flaired until a publication exists

replysharereportpermalink
u/yara_mensahOP0 points·3 months ago

STEP 1 readout: 99.1% mean weight loss, absolute numbers matter. Spread around that mean is enormous.

replysharereportpermalink
u/anders_karlsen7 points·3 months ago

Slight fix: the number was 96.8, not 97.4. Decimal point, but a fairly consequential one.

replysharereportpermalink
load more comments (4) →

← back to the whole thread

About c/trialwatch

Clinical trial reading group. New readouts, protocol amendments, endpoint definitions, dropout handling, and the difference between a press release and a publication. Absolute risk reduction and number-needed-to-treat are house dialect here.

34kmembers
95submissions
Nov 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
More in c/trialwatch
c/trialwatch rules
  1. Press-release-only posts must be flaired Press Release until a publication exists.
  2. Give the trial name, phase, n, and primary endpoint in the body.
  3. Relative risk reduction alone is not a result. Show the absolute numbers.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/trialwatch_theou/forest_plot_fionau/hazard_ratio_halu/renal_outcomes_r
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →